MBX
MBX Biosciences, Inc.
$55.94+1.43 (+2.62%)Close Nov 13, 2026
Sep 13, 2024 – Nov 13, 2026, Dividends reinvested
- Final balance
- $23,653
- CAGR
- +48.82%
- Max drawdown
- −77.71%
- Sharpe ratio
- 0.83
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
Total
- 1M
- +14.16%
- 3M
- −16.61%
- 6M
- +49.17%
- YTD
- +77.36%
- 1Y
- +132.41%
Per year
- Since 2024
- +48.82%
Annual returns
2024 from Sep 13 · 2026 through Nov 13
MBX returns by year
| Year | Return |
|---|---|
| 2026 through Nov 13 | +77.36% |
| 2025 | +71.13% |
| 2024 from Sep 13 | −22.07% |
Metrics
Since 2024| Volatility | 110.27% |
|---|---|
| Sortino ratio | 1.59 |
| Calmar ratio | 0.63 |
| Best year, 2025 | +71.13% |
| Worst year, 2025 | +71.13% |
| Positive years | 1 of 1 |
| Longest drawdown | 1.1 years |
Worst drawdowns
Since 2024| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −77.7% | Sep 2024 | Apr 2025 | Nov 2025 | 1.1 years |
| −37.6% | Jan 2026 | Mar 2026 | Jun 2026 | 5 months |
| −31.5% | Aug 2026 | Nov 2026 | Not yet | 3 months so far |
| −19.7% | Nov 2025 | Dec 2025 | Dec 2025 | 3 weeks |
| −17.5% | Dec 2025 | Jan 2026 | Jan 2026 | 3 weeks |